Free Trial
NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

iSpecimen logo
$3.00 +0.04 (+1.35%)
(As of 12/20/2024 05:45 PM ET)

About iSpecimen Stock (NASDAQ:ISPC)

Key Stats

Today's Range
$2.98
$3.97
50-Day Range
$2.92
$6.30
52-Week Range
$2.76
$12.20
Volume
2.42 million shs
Average Volume
212,281 shs
Market Capitalization
$2.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

iSpecimen Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
18th Percentile Overall Score

ISPC MarketRank™: 

iSpecimen scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iSpecimen.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iSpecimen is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iSpecimen is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    iSpecimen has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.05% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently decreased by 56.80%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    iSpecimen does not currently pay a dividend.

  • Dividend Growth

    iSpecimen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.05% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently decreased by 56.80%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    iSpecimen has a news sentiment score of -0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for iSpecimen this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for ISPC on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iSpecimen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.20% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 13.62% of the stock of iSpecimen is held by institutions.

  • Read more about iSpecimen's insider trading history.
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
iSpecimen Appoints Robert Lim as New CEO
iSpecimen Inc. Reports Earnings Amid Financial Challenges
iSpecimen Reports Third Quarter 2024 Results
iSpecimen releases cancer biospecimen offering
See More Headlines

ISPC Stock Analysis - Frequently Asked Questions

iSpecimen's stock was trading at $0.5006 at the beginning of the year. Since then, ISPC stock has increased by 499.3% and is now trading at $3.00.
View the best growth stocks for 2024 here
.

iSpecimen Inc. (NASDAQ:ISPC) issued its earnings results on Tuesday, August, 6th. The company reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.28) by $0.09. The firm earned $2.86 million during the quarter. iSpecimen had a negative net margin of 91.66% and a negative trailing twelve-month return on equity of 139.25%.

iSpecimen (ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and Braze (BRZE).

Company Calendar

Last Earnings
8/06/2024
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
Business Services
Current Symbol
NASDAQ:ISPC
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

Net Income
$-11,100,000.00
Pretax Margin
-91.65%

Debt

Sales & Book Value

Annual Sales
$10.39 million
Book Value
$21.47 per share

Miscellaneous

Free Float
846,000
Market Cap
$2.89 million
Optionable
Not Optionable
Beta
1.57
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ISPC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners